vincamine has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braun, D; Feinstein, DL | 1 |
| Araie, M; Koseki, N; Shirato, S; Yamagami, J; Yamamoto, S | 1 |
1 trial(s) available for vincamine and Disease Exacerbation
| Article | Year |
|---|---|
Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure.
Topics: Administration, Oral; Chronic Disease; Disease Progression; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Optic Disk; Prospective Studies; Treatment Outcome; Vasodilator Agents; Vincamine; Visual Fields | 1999 |
1 other study(ies) available for vincamine and Disease Exacerbation
| Article | Year |
|---|---|
The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer's disease.
Topics: Adrenergic Neurons; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Disease Progression; Hippocampus; Locus Coeruleus; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Degeneration; Neurons; Neuroprotective Agents; Norepinephrine; Phosphodiesterase I; Vincamine | 2019 |